not tagged
abbott
['triluminate']
at #acc23: the triluminate pivotal trial reports a reduction in the severity of tricuspid regurgitation with transcatheter repair, but no significant difference in survival or hospitalization after one year of follow-up. read more: 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.